| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |